Latest Breaking News On - Exchangeable senior notes - Page 1 : comparemela.com

PennyMac Mortgage Investment Trust Prices Private Placement of $200 Million of Exchangeable Senior Notes

PennyMac Mortgage Investment Trust today announced the pricing of a private offering by its indirect wholly-owned subsidiary, PennyMac Corp. , of $200 million aggregate principal amount of its.

United statesSecurities exchangeYork stock exchange onInvestment companyPennymac corpPennymac financial services incExchange commissionPennymac loan servicesPennymac mortgage investment trustPennymac mortgage investmentCapital managementConsumer financial protection bureauExchangeable senior notesSecurities actCommon shareNew york stock exchange

PennyMac Mortgage Investment Trust Announces Proposed Private Placement of Exchangeable Senior Notes

PennyMac Mortgage Investment Trust today announced that its indirect wholly-owned subsidiary, PennyMac Corp. , plans to make a private offering of $200 million aggregate principal amount of its.

United statesPennymac loan servicesConsumer financial protection bureauPennymac mortgage investment trustSecurities exchangePennymac mortgage investmentPennymac corpInvestment companyCapital managementExchange commissionPennymac financial services incExchangeable senior notesSecurities actCommon sharesMac mortgage investment trustPennymac financial services

Jazz Pharmaceuticals plc: Jazz Pharmaceuticals Announces First Quarter 2024 Financial Results and Affirms 2024 Financial Guidance

Jazz Pharmaceuticals plc: Jazz Pharmaceuticals Announces First Quarter 2024 Financial Results and Affirms 2024 Financial Guidance
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Bruce cozaddRedx pharmaAndrean flynnExperte carsten storkRylaze enrylazeEpidiolex epidyolexZwei rohstoff chancenKristin bhavnaniExchange commissionPrnewswire jazz pharmaceuticalsJazz pharmaceuticalsAccess programEuropean medicines agencyCompany annual report on formHead of global corporate communicationsEpidyolex phase

Jazz Pharmaceuticals Announces First Quarter 2024 Financial Results and Affirms 2024 Financial Guidance

– 12% year-over-year revenue increase from combined key growth drivers: Xywav®, Epidiolex® and Rylaze® –– Oncology revenues grew 13% year-over-year –– Submitted zanidatamab BLA for 2L.

Bruce cozaddEpidiolex epidyolexRedx pharmaRylaze enrylazeKristin bhavnaniAndrean flynnAccess programCompany annual report on formHead of global corporate communicationsPrnewswire jazz pharmaceuticalsEuropean medicines agencyJazz pharmaceuticalsExchange commissionTop line phaseEpidyolex phaseIdiopathic hypersomnia

ANYWHERE REAL ESTATE INC REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS

/PRNewswire/ Anywhere Real Estate Inc. (NYSE: HOUS) ("Anywhere" or the "Company"), a global leader in residential real estate services, today reported.

United statesRyan schneiderCharlotte simonelliCompany senior secured leverage ratioAmerica most innovative companiesWorld best companiesRevenues for franchise groupTitle groupReal estate incPrnewswire anywhere real estate incWorld most ethical companiesSotheby international realtyCompany operatingReal estate groupCompany net debt leverage ratioFranchise group